FKBP5 and anxiety disorder: For further development of FKBP51 antagonists as potential ADs and anxiolytics, it is important to understand whether pharmacological FKBP51 inhibition interferes with the action of commonly prescribed ADs, which are also often prescribed for anxiety disorders.